Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Year-over-year net income growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-1.8x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -180.81% |
| Q3 2025 | 6.09% |
| Q2 2025 | 39.85% |
| Q1 2025 | -13.81% |
| Q4 2024 | 0.00% |
| Q3 2024 | 46.94% |
| Q2 2024 | 21.38% |
| Q1 2024 | -10.03% |
| Q4 2023 | 4.34% |
| Q3 2023 | 9.48% |
| Q2 2023 | 88.70% |
| Q1 2023 | -31.35% |
| Q4 2022 | -6.38% |
| Q3 2022 | 171.69% |
| Q2 2022 | -62.26% |
| Q1 2022 | -9.98% |
| Q4 2021 | -69.17% |
| Q3 2021 | 136.82% |
| Q2 2021 | 227.87% |
| Q1 2021 | -61.87% |
| Q4 2020 | 102.07% |
| Q3 2020 | 40.24% |
| Q2 2020 | 523.02% |
| Q1 2020 | 82.26% |
| Q4 2019 | -37.51% |
| Q3 2019 | -71.05% |
| Q2 2019 | -914.25% |
| Q1 2019 | 184.48% |
| Q4 2018 | 92.37% |
| Q3 2018 | -21.65% |
| Q2 2018 | 16.63% |
| Q1 2018 | -122.17% |
| Q4 2017 | 4406.44% |
| Q3 2017 | 108.94% |
| Q2 2017 | 6.49% |
| Q1 2017 | -20.12% |
| Q4 2016 | 5.39% |
| Q3 2016 | -7.71% |
| Q2 2016 | -35.62% |
| Q1 2016 | -558.92% |